Article
Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Dec 2012
Pérez-Ruiz Elisabeth, Rueda A, Pereda T, Alcaide J, Bautista D, Rivas-Ruiz F, Villatoro R, Pérez D, Redondo M
Abstract excerpt
The efficacy of epidermal growth factor-targeting therapies has been found to be limited in tumors with the wild-type K-RAS gene, suggesting a predictive value of K-RAS gene analysis in tumoral response. However, the prognostic value of K-RAS is controversial. This study included patients diagnosed with metastatic colorectal cancer. The presence of K-RAS mutations was analyzed, and the tumors positive for a K-RAS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
